Granddaddy of human blood cells
17 December, 2007 by Staff WritersUS researchers have isolated the multipotent progenitor cell in humans for the first time.
Antibody homes in on leukaemic stem cells
13 December, 2007 by Kate McDonaldAustralia's largest biotechnology company, CSL, has released preliminary data on a novel antibody therapy for acute myeloid leukaemia.
Immunology feature: landlords, tenants and immune response
04 December, 2007 by Graeme O'NeillMariapia Degli-Esposti's team at Perth's Lions Eye Institute is looking closely at why the immune system puts up a good fight against some viral infections but has problems with others.
Myc-less mice produce stem cells
03 December, 2007 by Kate McDonaldThe Japanese team that proved how to induce stem cells from human skin seems to have overcome the Myc tumorigenesis barrier.
Immunology feature: Bim, Bid and autoimmunity
03 December, 2007 by Fiona WylieThe Australasian Society for Immunology is holding its annual conference this week. Key note speaker Andreas Strasser will discuss his latest findings on the functions of apoptosis-related proteins in the immune system.
Seeing the light in femtoseconds
28 November, 2007 by Kate McDonaldSpeedy laser facility will be used for biological imaging.
Four-gene cocktail for stem cells
21 November, 2007 by Kate McDonaldTwo teams, six genes and the transformation of adult skin cells into induced pluripotent stem cells.
First cloned primate embryos
15 November, 2007 by Kate McDonaldFor the first time, embryonic stem cell lines have been derived from monkeys using SCNT.
Chinese stem cell venture for Monash
01 November, 2007 by Staff WritersMonash and Peking unis in stem cell research agreement.
Muscle stem cells on SCS menu
24 October, 2007 by Kate McDonaldStem Cell Sciences adds pericyte cell types to list of products for research.
AusBiotech profile: Plasvacc
18 October, 2007 by Kate McDonaldWe profile Queensland veterinary biotech Plasvacc, which develops plasma products as an alternative to antibiotics.
Boning up on mesenchymal stem cells
16 October, 2007 by Kate McDonaldAs it begins Phase IIa clinical trials, Mesoblast is riding high: its share price is climbing, its market capitalisation is booming and all that promise seems to be coming good.
Hearty news for stem cells
10 August, 2007 by Staff WritersMesoblast sees heart muscle recovery in Newcastle pilot trial.
The limitations of the nose
02 August, 2007 by Staff WritersVery few things are more important in life than a good glass of wine, which is why scientists are poking their noses into it.
Differences of opinion in coeliac disease
20 July, 2007 by Kate McDonaldThe treatment of coeliac disease could be tailored to individual genetic make-up following a Victorian research breakthrough.
